High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast CancerSjoerd Rodenhuis, Elisabeth G.E. de Vries, Emile E. Voest et al.|New England Journal of Medicine|2003Cited by 262
Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational TrialC. Schilder, Sanne B. Schagen, F. S. van Dam et al.|Journal of Clinical Oncology|2010Cited by 261
“Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancerE Engelsman, Richard Sylvester, J.C.M. Klijn et al.|European Journal of Cancer and Clinical Oncology|1991Cited by 165